Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.49 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | OGA | O60502 | 3/20 | 0.42 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | KIT | P10721 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28608204 | 0.98 | CNR2 (0.48) | CNR2UBE2TMAPTALDH1A1LMNA | |
| Hydrochloric Acid SCHEMBL28608203 | 0.98 | CNR2 (0.48) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL4547927 | 0.88 | CNR2 (0.50) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL14147094 | 0.87 | HTR3A (0.46) | ALDH1A1OGA | |
| SCHEMBL13466366 | 0.86 | CNR2 (0.48) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL14349207 | 0.82 | PANK3 (0.46) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL18930172 | 0.82 | MEN1 (0.47) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL14217158 | 0.82 | UBE2T (0.45) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL14217201 | 0.82 | UBE2T (0.45) | CNR2UBE2TMAPTALDH1A1LMNA | |
| SCHEMBL19122027 | 0.81 | MAPT (0.43) | CNR2UBE2TMAPTALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020154431-A1 | INHIBITORS OF SPINSTER HOMOLOG 2 (SPNS2) FOR USE IN THERAPY | LYNCH KEVIN R (US) | 2020-07-30 | — | — | WO | disclosed |